news ITM-11 boosts survival in neuroendocrine tumour trial 3 February 2025 | By Drug Target Review A new targeted radiotherapy offers hope for patients with rare neuroendocrine tumours, demonstrating a significant improvement in progression-free survival in a key clinical trial.
news New organoid model of neuroendocrine tumours developed 13 December 2023 | By Drug Target Review NETs require epidermal growth factor to grow, meaning that inhibiting EGF receptors could treat these types of tumours.
news Research reveals CDH17 represents a new approach to treat solid cancers 29 March 2022 | By Ria Kakkad (Drug Target Review) Pre-clinical research has found that CAR T cells can suppress gastrointestinal cancer cells without causing harm to healthy tissues.